"A ripper quarter": How Atlassian's SaaS business model is rewriting the valuation rules

Here's why SaaS or software-as-a-service companies are setting share markets alight.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia's greatest tech success story in software developer Atlassian (TEAM: NASDAQ) this morning reported what its own co-CEOs described as a "ripper" quarter ending December 31 2018.

The group has taken on an acquisitive business plan recently with significant deals to buy workplace messaging board Trello  (largely for IT teams) and digital incident management system Opsgenie.

As a result of the acquisitions and the still strong performance of its core Jira and Confluence businesses it managed to grow quarterly revenue 29% to US$299 million and ended the quarter with total customers of 138,825.

Its operating loss narrowed to US$3.2 million compared to US$13 million in the prior corresponding quarter, with adjusted net operating income coming in at US$74.8 million.

The difference between the two is because Atlassian, like every other company, backs out costs such as share-based compensation and amortisation of acquired intangible assets when reporting adjusted income.

For the third quarter of FY 2019 it's targeting revenue between US$303 million to US$305 million, with net adjusted earnings per share of 18 cents.

Valuation

For the full year it's targeting revenue between US$1,195 million and US$1,199 million on adjusted earnings per share between 81 to 82 cents. This would place the stock on 113x estimated adjusted forward earnings per share based on a US$92 share price. It would also be on 18.4x estimated annual sales based on a market cap of US$22.1 billion.

Evidently investors are expecting a lot more profit growth from Atlassian thanks to its software-as-a-service business model that has potential to grow profits quickly on high margins over the long term.

I've written a fair bit about the rise of the software-as-a-service for investors to watch over 2018/19 and in particular how it appears to be re-writing the rules of conventional valuation as we see with Atlassian.

There are a few reasons for this covered in this article I wrote back in September on why SaaS shares going are gangbusters as investors in Australia wake up to the attractive economics of SaaS businesses over the long term.

Some professional analysts are also starting to think independently from traditional university or business school finance teachings on valuation to put lower discount rates on these stocks and hence increase their valuations.

This is because the recurring revenue model provides greater revenue and profit certainty over time that gives them more certainty over the present value of future cash flows. Consequently this turn present values higher as the future cash flows are discounted less for the risk they never materialise.

As such I flagged in the September article how the best SaaS stocks look worth owning such as Xero Limited (ASX: XRO), Nearmap Ltd (ASX: NEA) and Pro Medicus Limited (ASX: PME). All three of these stocks and several others have gone gangbusters on the ASX over the last few years and may have bright futures ahead.

However, please remember no stock is a buy at any price and the most highly-valued stocks are vulnerable to the biggest falls in the event of operational mishaps, while it's also easy to argue that some of the SaaS companies are over-valued on hype even if they do boast attractive business models.

Tom Richardson owns shares of Nearmap Ltd., Pro Medicus Ltd., and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. and Pro Medicus Ltd. The Motley Fool Australia owns shares of Xero. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was another woeful day for investors this Wednesday.

Read more »